We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Wants to Clear Forgotten ANDAs as Congress Nears GDUFA Passage
FDA Wants to Clear Forgotten ANDAs as Congress Nears GDUFA Passage
June 15, 2012
The FDA’s Office of Generic Drugs (OGD) appears to be taking the first steps to whittling down its almost 3,000-long ANDA backlog, telling drugmakers it will discard 364 pending generic-drug applications unless told otherwise.